drugset / Trial / NCT01580423

The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing

NCT01580423

Completed 16 enrolled Dartmouth-Hitchcock Medical Center
RandomizedCrossoverQuadruple-blindBasic science

Summary

Substance P is released from sensory nerves and transmits pain information into the central nervous system. As pain and dyspnea share many characteristics, including similar neurological pathways, it is possible that substance P may contribute to the sensation of dyspnea. The hypothesis of the study is that patients with chronic obstructive pulmonary disease (COPD) will provide lower ratings of breathlessness during resistive load breathing with oral aprepitant, a medication that blocks the activity of substance P, compared with placebo.

Timeline

Start
2012-04
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified 125 mg Oral